Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Elephas Biosciences Corp

Elephas Biosciences Corp

Stage unknownMadison, WIOther Health Care
Facts
Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
$40.0Msum of rounds with a disclosed amount only
Named investors
6
Financing history
2 rounds
  1. Nov 6, 2025
    Funding round · $40.0M (disclosed)
    Northpond Ventures, LLC (participant)Arch Venture Partners (participant)State of Wisconsin Investment Board (participant)Tao Capital Partners (participant)Venture Investors Health Fund (participant)Sands Capital Ventures, LLC (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “ELEPHAS BIOSCIENCES RAISES $40M TO ACCELERATE COMMERCIALIZATION OF ITS LIVE TUMOR PROFILING PLATFORM”
  2. Nov 30, 2023
    Form D equity offering · $51.2M (form d sold) · 10 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Elephas Biosciences Corp filed Form D: $51,218,994 sold of $55,000,000, Other Health Care”
Investors on record
6 edges
People
2 officers, 3 directors
Timeline
2
  1. Nov 6, 2025
    ELEPHAS BIOSCIENCES announced Funding round of $40,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
  2. Jan 9, 2024
    Elephas Biosciences Corp filed Form D: $51,218,994 sold of $55,000,000, Other Health Care
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this company